Your institution may have access to this item. Find your institution then sign in to continue.
Title
Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study.
Authors
Nauck MA; Ellis GC; Fleck PR; Wilson CA; Mekki Q
Publication
International journal of clinical practice, 2009, Vol 63, Issue 1, p46